Skip to content

Penumbra Coil 400 4002C0412Recalls & reported problems

Penumbra, Inc. · PC400 Cplx Std, 4x12 · Class 2 · Implant

All models of Penumbra Coil 400 (120)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI M4244002C04120), received between Aug 21, 2015 and Aug 21, 2015 — classified as 1 malfunction.

The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Activation, Positioning or Separation Problem1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 21, 2015Activation, Positioning or Separation Problem

    THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE CAROTID ARTERY USING A PENUMBRA COIL 400 (PC400 COIL). DURING THE PROCEDURE, THE PC400 COIL BECAME STRETCHED WHILE DEPLOYING INTO THE ANEURYSM. THE PHYSICIAN SUCCESSFULLY REMOVED THE DAMAGED COIL BY REMOVING THE MICROCATHETER AND PC400 COIL TOGETHER. THE PROCEDURE SUCCESSFULLY CONTINUED USING ANOTHER MANUFACTURER'S DEVICES. THERE WAS NO REPORT OF AN ADVERSE EFFECT ON THE PATIENT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 5023055 ↗

Other DEVICE, NEUROVASCULAR EMBOLIZATION devices

All DEVICE, NEUROVASCULAR EMBOLIZATION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page